Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2026-01-23 @ 3:46 PM
Study NCT ID:
NCT02280460
Status:
TERMINATED
Last Update Posted:
2024-06-05
First Post:
2014-10-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
ECMO: Optimization of Its Use
Sponsor:
Renzo Loyaga Rendon
Organization:
Study Overview
Official Title:
Extracorporeal Membrane Oxygenation(ECMO): Optimization of Its Use
Status:
TERMINATED
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Study was not able to achieve primary objective and there is no intention to work towards its achievement
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To create a local registry for ECMO patients.
Detailed Description:
To create a local registry of retrospective and prospective patients on ECMO at Spectrum Health, Butterworth campus in order to optimize the use of ECMO therapy and to create algorithms to estimate the prognosis. ECMO patients will be compared to a control group of patients. Patient mortality will be assessed in-house, at 48 hours, 3 months, and 1 year after the start of ECMO therapy.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: